Mar 10, 2021 / 08:35PM GMT
Balaji V. Prasad - Barclays Bank PLC, Research Division - Director
Good afternoon, everyone. My name is Balaji Prasad. I lead the specialty pharma coverage for Barclays. A part of this responsibility also is covering the animal health space. And so today, we have with us the management team from Phibro, and we have Jack Bendheim, CEO, President and Chairman; Damian Finio, CFO; and Daniel Bendheim, EVP of Business Strategy. Jack, Donny, Damian, thank you all for taking your time to join us today. A pleasure to see you here.
Jack Clifford Bendheim - Phibro Animal Health Corporation - Chairman, President & CEO
Thank you.
Damian Finio - Phibro Animal Health Corporation - CFO
Thank you.
Questions and Answers:
Balaji V. Prasad - Barclays Bank PLC, Research Division - DirectorSo the format will be a fireside chat one where we can get into Q&A directly. So for those who have dialed in, I -- there will be no Q&A session post the session. So let me just kick off by